Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study-Reference-Cited by-同舟云学术

Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study

Published:2015-12 Issue:8 Volume:18 Page:956-968
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Haeussler Katrin,Marcellusi Andrea,Mennini Francesco Saverio,Favato Giampiero,Picardo Mauro,Garganese Giorgia,Bononi Marco,Costa Silvano,Scambia Giovanni,Zweifel Peter,Capone Alessandro,Baio Gianluca

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference130 articles.

1. Genital human papillomavirus infection;Dunne;Clin Infect Dis,2006

2. Loss of health utilities due to HPV-induced diseases in men and women: a multicenter Italian study;Mennini;Value Health,2013

3. Colorectal Cancer Screening Options Appraisal: Cost-Effectiveness, Cost-Utility and Resource Impact of Alternative Screening Options for Colorectal Cancer;Tappenden;Report to the English Bowel Cancer Screening Working Group,2004

4. The cost-effectiveness of community-based screening for oral cancer in high-risk males in the United States: a Markov decision analysis approach;Dedhia;Laryngoscope,2011

5. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century;Coleman;Ann Oncol,2003

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incremental net benefit of extending human papillomavirus vaccine to boys in oropharyngeal cancer burden: Meta-analysis of cost-effectiveness studies;Journal of Dental Sciences;2024-10

2. Cost-effectiveness of the screen-and-treat strategies using HPV test linked to thermal ablation for cervical cancer prevention in China: a modeling study;BMC Medicine;2023-04-17

3. Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella;PharmacoEconomics;2023-02-21

4. What Are the Barriers to Human Papillomavirus Vaccination for Male in South Korea?;Urogenital Tract Infection;2022-12-31

5. The Clinical and Economic Impact of a Nonavalent Versus Bivalent Human Papillomavirus National Vaccination Program in Taiwan;Value in Health Regional Issues;2022-11